Regulatory approval clears the path for Valtech to market its implantable mitral reconstruction device in European markets MR is a vastly underserved condition in which the mitral valve leaflets fail ...
OR YEHUDA, Israel, Valtech Cardio, Ltd., an innovator in the development of surgical and transcatheter devices for mitral and tricuspid valve repair and replacement, announces planned activities at ...
OR YEHUDA, Israel, Sept. 14, 2015 /PRNewswire/ -- Valtech Cardio, Ltd., (Valtech), an innovator in the development of devices for mitral and tricuspid valve repair and replacement, announced today it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results